These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38002606)

  • 21. Does transient hyperprolactinemia during ovarian hyperstimulation interfere with conception or pregnancy outcome?
    Gonen Y; Casper RF
    Fertil Steril; 1989 Jun; 51(6):1007-10. PubMed ID: 2721718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model.
    Hortu I; Karadadas E; Ozceltik G; Tavmergen E; Tavmergen Goker EN; Yigitturk G; Erbas O
    Arch Gynecol Obstet; 2021 Apr; 303(4):1099-1108. PubMed ID: 33140116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel neuropeptide phoenixin is highly co-expressed with nesfatin-1 in the rat hypothalamus, an immunohistochemical study.
    Pałasz A; Rojczyk E; Bogus K; Worthington JJ; Wiaderkiewicz R
    Neurosci Lett; 2015 Apr; 592():17-21. PubMed ID: 25736948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial.
    Zheng X; Guo W; Zeng L; Zheng D; Yang S; Xu Y; Wang L; Wang R; Mol BW; Li R; Qiao J
    Hum Reprod; 2022 Jan; 37(2):242-253. PubMed ID: 34849920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy-Associated Ovarian Torsion - a Single-Center Case-Control Study.
    Meyer R; Meller N; Amitai Komem D; Abu-Bandora E; Cohen A; Cohen SB; Mashiach R; Levin G
    Reprod Sci; 2023 Jun; 30(6):1998-2002. PubMed ID: 36576712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotection.
    Rocca C; Scavello F; Granieri MC; Pasqua T; Amodio N; Imbrogno S; Gattuso A; Mazza R; Cerra MC; Angelone T
    Cell Mol Life Sci; 2018 Feb; 75(4):743-756. PubMed ID: 28965207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of unabated stimulation by human chorionic gonadotropin on the steroid hormone environment of pregnant rats and the spontaneous expression of ovarian cysts in female progeny.
    Bogovich K
    Endocrine; 2008 Apr; 33(2):152-64. PubMed ID: 18481228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress and polycystic ovary syndrome: evaluation during ovarian stimulation for ICSI.
    Melo AS; Kliemchen J; Junior AA; Ferriani RA; Navarro PA
    Reproduction; 2016 Oct; ():. PubMed ID: 27799629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Phoenixin-14 on anxiolytic-like behavior in mice.
    Jiang JH; He Z; Peng YL; Jin WD; Mu J; Xue HX; Wang Z; Chang M; Wang R
    Behav Brain Res; 2015 Jun; 286():39-48. PubMed ID: 25687846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ; Samson WK
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An interplay of Progesterone, Leukemia Inhibitor Factor and Interleukin-6 in the window of implantation; Impact on fertility.
    Ali R; Ahmed Khan T; Gul H; Rehman R
    Cytokine; 2023 Oct; 170():156332. PubMed ID: 37586287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.
    Santoro N; Eisenberg E; Trussell JC; Craig LB; Gracia C; Huang H; Alvero R; Casson P; Christman G; Coutifaris C; Diamond M; Jin S; Legro RS; Robinson RD; Schlaff WD; Zhang H;
    Hum Reprod; 2016 Oct; 31(10):2268-79. PubMed ID: 27402910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient hyperprolactinemia in gonadotropin-stimulated cycles for in vitro fertilization and its effect on conception.
    Chang SP; Ng HT; Lan TL; Chao HT; Wei TC; Yang TS; Ou-Yang XR
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):401-6. PubMed ID: 8281485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic oxidative stress is not associated with live birth rate in young non-obese patients with polycystic ovarian syndrome undergoing assisted reproduction cycles: A prospective cohort study.
    Chen M; Huang X; Liu Y; Lei S; Wu Y; Chen Z; Hong L; Teng X
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():154-161. PubMed ID: 32877771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does plasma phoenixin level associate with cognition? Comparison between subjective memory complaint, mild cognitive impairment, and mild Alzheimer's disease.
    Yuruyen M; Gultekin G; Batun GC; Yavuzer H; Akcan FE; Doventas A; Emul M
    Int Psychogeriatr; 2017 May; ():1-8. PubMed ID: 28552081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Retrospective Study of Letrozole Treatment Prior to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization at Risk of Ovarian Hyperstimulation Syndrome.
    Chen Y; Yang T; Hao C; Zhao J
    Med Sci Monit; 2018 Jun; 24():4248-4253. PubMed ID: 29925074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.